Intracranial hypertension due to Epstein-Barr virus encephalitis during the postpartum period A case report
Keywords:
adult, brain edema, cerebrospinal fluid, Epstein-Barr virus infections, intracranial pressure, intracranial hypertension, treatment outcome, postpartum period, encephalitisMain Article Content
Case Description
A 28-year-old postpartum woman presented with severe headache, fever, and decreased level of consciousness. Cerebrospinal fluid PCR detected 185,000 copies of Epstein-Barr virus DNA.
Clinical Findings
Neuroimaging revealed diffuse cerebral edema consistent with intracranial hypertension in the absence of hemorrhagic lesions, confirming Epstein-Barr virus encephalitis complicated by objectively documented elevated intracranial pressure.
Treatment and Outcomes
The patient received intravenous acyclovir, phenytoin, and hypertonic saline, achieving complete neurological recovery after 21 days of therapy.
Clinical Relevance
To our knowledge, this is the first documented case of non-hemorrhagic Epstein-Barr virus encephalitis with objectively confirmed intracranial hypertension in the postpartum period. The most plausible mechanism is inflammation-induced diffuse cerebral edema leading to impaired cerebrovascular autoregulation and subsequent intracranial pressure elevation. Clinicians should include Epstein-Barr virus infection in the differential diagnosis of postpartum patients presenting with encephalitis and signs of increased intracranial pressure, even when neuroimaging does not reveal hemorrhagic findings.
1. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas y Bennett. Enfermedades infecciosas. Principios y práctica. 9th edition. España:Elsevier; 2020.
2. Tsuruyama Y, Mori N, Yoshida S, Hayashi T. Epstein-Barr virus-related encephalitis in a young woman: A case report. J Infect Chemother. 2020;26(7):741-744. https://doi.org/10.1016/j.jiac.2020.02.005. PMid:32147376 DOI: https://doi.org/10.1016/j.jiac.2020.02.005
3. Huang L, Zhang X, Fang X. Case Report: Epstein-Barr Virus encephalitis complicated with brain stem hemorrhage in an immune-competent adult. Front Immunol. 2021;12:618830. https://doi.org/10.3389/fimmu.2021.618830. PMid:33717113; PMCid:PMC7947888 DOI: https://doi.org/10.3389/fimmu.2021.618830
4. Takeuchi S, Takasato Y, Masaoka H, Hayakawa T, Otani N, Yoshino Y, et al. Hemorrhagic encephalitis associated with Epstein-Barr virus infection. J Clin Neurosci. 2010;17(1):153-154. https://doi.org/10.1016/j.jocn.2009.03.043. PMid:20004100 DOI: https://doi.org/10.1016/j.jocn.2009.03.043
5. Hayton E, Wakerley B, Bowler IC, Bogdanovic M, Adcock JE. Successful outcome of Epstein–Barr virus encephalitis managed with bilateral craniectomy, corticosteroids and aciclovir. Pract Neurol. 2012;12(4):234-7. https://doi.org/10.1136/practneurol-2012-000234. PMid:22869765 DOI: https://doi.org/10.1136/practneurol-2012-000234
6. Mierzewska-Schmidt M, Piwowarczyk A, Szymanska K, Ciaston M, Podsiadly E, Przybylski M, et al. Fatal fulminant Epstein–Barr Virus (EBV) encephalitis in immunocompetent 5.5-year-old girl-a case report with the review of diagnostic and management dilemmas. Biomedicines. 2024;12(12):2877. https://doi.org/10.3390/biomedicines12122877. PMid:39767783; PMCid:PMC11673975 DOI: https://doi.org/10.3390/biomedicines12122877
7. Peuchmaur M, Voisin J, Vaillant M, Truffot A, Lupo J, Morand P, et al. Epstein-Barr Virus Encephalitis: a review of case reports from the last 25 years. Microorganisms. 2023;11(12):2825. https://doi.org/10.3390/microorganisms11122825. PMid:38137968; PMCid:PMC10745555 DOI: https://doi.org/10.3390/microorganisms11122825
8. Liu Z, Peng A, Huang L, Sha L, Tang Y, Zhou Y, et al. Clinical features and risk factors for Epstein-Barr virus-associated encephalitis: a retrospective cohort study. Virol J. 2025;22(1):141. https://doi.org/10.1186/s12985-025-02768-w. PMid:40361209; PMCid:PMC12076911 DOI: https://doi.org/10.1186/s12985-025-02768-w
9. Costa BK da, Sato DK. Viral encephalitis: a practical review on diagnostic approach and treatment. J Pediatr (Rio J). 2020;96(Suppl 1):12-19. https://doi.org/10.1016/j.jped.2019.07.006. PMid:31513761; PMCid:PMC9431993 DOI: https://doi.org/10.1016/j.jped.2019.07.006
10. Shin YW, Sunwoo JS, Lee HS, Lee WJ, Ahn SJ, Lee SK, et al. Clinical significance of Epstein-Barr virus polymerase chain reaction in cerebrospinal fluid. Encephalitis. 2022;2(1):1-8. https://doi.org/10.47936/encephalitis.2021.00115. PMid:37469607; PMCid:PMC10295909 DOI: https://doi.org/10.47936/encephalitis.2021.00115
11. Cheng H, Chen D, Peng X, Wu P, Jiang L, Hu Y. Clinical characteristics of Epstein–Barr virus infection in the pediatric nervous system. BMC Infect Dis. 2020;20(1):886. https://doi.org/10.1186/s12879-020-05623-1. PMid:33238935; PMCid:PMC7691062 DOI: https://doi.org/10.1186/s12879-020-05623-1
Downloads

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
